Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1

Detalles Bibliográficos
Autores principales: Zabriskie, Matthew S., Vellore, Nadeem A., Gantz, Kevin C., Deininger, Michael W., O’Hare, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536190/
https://www.ncbi.nlm.nih.gov/pubmed/25676420
http://dx.doi.org/10.1038/leu.2015.42
_version_ 1782385702921568256
author Zabriskie, Matthew S.
Vellore, Nadeem A.
Gantz, Kevin C.
Deininger, Michael W.
O’Hare, Thomas
author_facet Zabriskie, Matthew S.
Vellore, Nadeem A.
Gantz, Kevin C.
Deininger, Michael W.
O’Hare, Thomas
author_sort Zabriskie, Matthew S.
collection PubMed
description
format Online
Article
Text
id pubmed-4536190
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-45361902016-03-01 Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1 Zabriskie, Matthew S. Vellore, Nadeem A. Gantz, Kevin C. Deininger, Michael W. O’Hare, Thomas Leukemia Article 2015-02-13 2015-09 /pmc/articles/PMC4536190/ /pubmed/25676420 http://dx.doi.org/10.1038/leu.2015.42 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Zabriskie, Matthew S.
Vellore, Nadeem A.
Gantz, Kevin C.
Deininger, Michael W.
O’Hare, Thomas
Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1
title Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1
title_full Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1
title_fullStr Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1
title_full_unstemmed Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1
title_short Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1
title_sort radotinib is an effective inhibitor of native and kinase domain-mutant bcr-abl1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536190/
https://www.ncbi.nlm.nih.gov/pubmed/25676420
http://dx.doi.org/10.1038/leu.2015.42
work_keys_str_mv AT zabriskiematthews radotinibisaneffectiveinhibitorofnativeandkinasedomainmutantbcrabl1
AT vellorenadeema radotinibisaneffectiveinhibitorofnativeandkinasedomainmutantbcrabl1
AT gantzkevinc radotinibisaneffectiveinhibitorofnativeandkinasedomainmutantbcrabl1
AT deiningermichaelw radotinibisaneffectiveinhibitorofnativeandkinasedomainmutantbcrabl1
AT oharethomas radotinibisaneffectiveinhibitorofnativeandkinasedomainmutantbcrabl1

Ejemplares similares